Home | UCSF Helen Diller Family Comprehensive Cancer Center

A human T cell. Image courtesy of NIH

Uncovering Why Cancer Immunotherapy Leads to Heart Inflammation

In a study led by UC San Francisco researchers that published Jan. 7 in Circulation, the researchers found that anti-LAG-3/anti-PD-1 combination therapy shows a higher risk of myocarditis compared to other ICI treatments.

UCSF Cancer Center Year in Review 2025

Year in Review: 2025

Though investments in partnerships and innovation, advances in targeted treatments and screening recommendations, our cancer community remained dedicated to not only treat cancer — but to prevent it, and to ensure that all communities benefit from scientific progress.

Dr. Laura Esserman

UCSF Study Finds a Better Way to Screen for Breast Cancer

A pioneering study has found that an individualized approach to breast cancer screening that assesses patients’ risk, rather than annual mammograms, can lower the chance of more advanced cancers, while still safely match people to the amount of screening they need.

A tanning bed emitting a soft blue glow.

Indoor Tanning Makes Youthful Skin Much Older on a Genetic Level

Research reveals that artificial sources of ultraviolet radiation cause cellular mutations that can be the seeds of future cancers, including highly deadly melanoma.

Cigarette and ashtray

Thirdhand Smoke: This Hidden Danger Puts Kids and Adults at Risk

UCSF researcher and leading advocate Neal Benowitz, MD, explains the threat of lingering tobacco residue and how a new California law could help.

KRAS Signalling pathway

From Undruggable to Unstoppable: A New Cancer Cure Target Emerges

NIH-funded discoveries by UCSF's Kevan Shokat, PhD have produced the world’s first drugs that target mutations in the KRAS gene which cause a quarter of all cancerous tumors.

SFMOMA - Art for Recovery exhibit viewed on opening night

Showcasing Art that Celebrates Creativity and Healing Amid Cancer

First of its kind display at SFMOMA by UCSF Health patients

Lee May UCSF Multiple Myeloma patient standing next to a fence by an open field

‘Every Time I Relapsed, There Would Be a New Course of Therapy’

He was told cancer would kill him in two to four years. Fourteen years later, he credits a series of medications and treatments funded by the National Institutes of Health.

Joan and Sandy Weill

Gift Launches $200M Initiative for the Weill Cancer Hub West

Matching grant from Weill family creates collaborative research hub, uniting scientists from UCSF and Stanford Medicine to transform cancer care within a decade.

Upcoming Events

Latest Video